Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis.

Journal

Journal for immunotherapy of cancer
ISSN: 2051-1426
Titre abrégé: J Immunother Cancer
Pays: England
ID NLM: 101620585

Informations de publication

Date de publication:
17 Apr 2019
Historique:
received: 27 11 2018
accepted: 29 11 2018
entrez: 19 4 2019
pubmed: 19 4 2019
medline: 19 4 2019
Statut: epublish

Résumé

Following publication of the original article [1], the authors reported an error in their listed affiliations.

Identifiants

DOI: 10.1186/s40425-018-0469-9 PMID: 30995944 PMC: PMC6469141
pubmed: 30995944
doi: 10.1186/s40425-018-0469-9
pii: 10.1186/s40425-018-0469-9
pmc: PMC6469141
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

107

Commentaires et corrections

Type : ErratumFor

Références

J Immunother Cancer. 2018 Oct 11;6(1):103
pubmed: 30305177

Auteurs

Daniel H Johnson (DH)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Chrystia M Zobniw (CM)

Division of Pharmacy, Clinical Section, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Van A Trinh (VA)

Division of Pharmacy, Clinical Section, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Junsheng Ma (J)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Roland L Bassett (RL)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Noha Abdel-Wahab (N)

Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Assiut University Hospitals, Assiut, Egypt.

Jaime Anderson (J)

Division of Pharmacy, Clinical Section, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jennifer E Davis (JE)

Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jocelyn Joseph (J)

Division of Pharmacy, Clinical Section, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Marc Uemura (M)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ali Noman (A)

Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Hamzah Abu-Sbeih (H)

Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Cassian Yee (C)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Rodabe Amaria (R)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Sapna Patel (S)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Hussein Tawbi (H)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Isabella C Glitza (IC)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Michael A Davies (MA)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Michael K Wong (MK)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Scott Woodman (S)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Wen-Jen Hwu (WJ)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Patrick Hwu (P)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Yinghong Wang (Y)

Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Adi Diab (A)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. adiab@mdanderson.org.

Classifications MeSH